EZH2 and ovarian carcinoma: In the present study, we demonstrated that HOTAIR/miR-138-5p axis could regulate the DDP-resistance of ovarian cancer by potential targets EZH2 and SIRT1, which could shed light on new therapeutic targets for ovarian cancer treatment.